Assessment of Growth Disturbance in Japanese Children with IBD

Table 2

Comparison of various parameters at initial assessment and 1 year after the start of treatment in children with CD and those with UC (mean ± SD).

	Admission			1 year after
	CD	UC		CD	UC
Alb (g/dL)	3.51±0.57	3.67±0.65	N.S.	4.36±0.33	4.24±0.39	N.S.
IGF-I (ng/mL)	270.9±219.6	231.8±166.1	N.S.	356.7±164.7	350.2±164.3	N.S.
CRP (mg/dL)	3.16±3.20	1.35±2.59	𝑃<.05	0.17±0.29	0.10±0.11	N.S.
IL-6 (pg/mL)	9.74±8.34	11.24±23.69	N.S.	2.93±2.20	2.28±3.73	N.S.
TNF-𝛼 (pg/mL)	0.76±1.17	0.98±2.19	N.S.	0.66±0.96	1.02±1.25	N.S.
TGF-𝛽 (ng/mL)	52.71±7.36	47.51±14.10	N.S.	47.80±5.13	44.68±12.89	N.S.